Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
AOD-9604 AOD 9604 Peptide Therapy: Discover the Benefits of AOD-9604 for Fat Reduction Conveniently located to serve Beverly Hills, Hollywood, Los Angeles, NYC, and Miami
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
These may include temporary dizziness, mild headache resolving within hours, slight fatigue (usually with higher doses), and occasional mild nausea
Together, they create a balanced healing environment where damaged tissue can repair efficiently without ongoing inflammatory interference
